Lucid Diagnostics LUCD
NASDAQ LUCD
$0.96 -0.05 (-4.73%)
At close: Aug 20, 2026 · 1:19 PM UTC

Lucid Diagnostics (LUCD) EPS (Diluted) Growth (3y) (2025 - 2026)

Lucid Diagnostics (LUCD) EPS (Diluted) Growth (3y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) Growth (3y) (Qtr)
1 Abbott Laboratories 198.95 Bn 193.35 Bn 7.27 Bn -12.16%
2 Stryker 128.10 Bn 124.63 Bn 4.50 Bn 19.81%
3 Medtronic 118.91 Bn 109.69 Bn 6.41 Bn 3.09%
4 Boston Scientific 73.43 Bn 72.89 Bn 3.85 Bn 50.83%
5 Edwards Lifesciences 51.91 Bn 47.66 Bn 1.35 Bn -6.12%
6 Dexcom 34.52 Bn 32.58 Bn 830.00 Mn 33.46%
7 GE HealthCare Technologies 33.94 Bn 31.83 Bn 2.18 Bn 11.48%
8 Koninklijke Philips 26.37 Bn 23.05 Bn 4.55 Bn 1,810.75%
9 Steris 23.14 Bn 22.66 Bn 684.20 Mn 18.07%
10 Lucid Diagnostics 176.26 Mn 142.85 Mn 55,000.00 20.63%

Historic Data

Download Data
DateValue
Jun 30, 2026 20.63%
Mar 31, 2026 18.06%
Dec 31, 2025 28.53%
Sep 30, 2025 37.52%
Jun 30, 2025 42.03%